Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...

Receiving a diagnosis for any disease/condition is not an easy experience. One organization hopes to make patients newly diagnosed with pulmonary fibrosis feel supported during this time via a new ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Boehringer Ingelheim (BI) and the UK Cystic Fibrosis Gene Therapy Consortium ... Ingelheim’s capabilities in drug discovery and the clinical development of novel breakthrough therapeutic agents.” ...

Bacteriophage MarketThe global bacteriophage market, valued at USD 45.07 million in 2023, is projected to reach USD 68 million by 2033, growing at a CAGR of 4.2% over the forecast period. The ...

Allergic bronchopulmonary aspergillosis is a pulmonary disease occurring in patients with asthma or cystic fibrosis ... least two radiological features suggestive of fibrosis † without presence ...

A new report released by the Alberta Medical Association says the number of Albertans without primary care, combined with ...

Longer term challenges, such as the slowdown of HTA outputs, delays to clinical trials and regulatory ... led by the gene therapy Zolgensma and the Cystic Fibrosis treatment Trikafta were the ...

Watch this video to see how clinical research has made a difference in the lives of people with CF. Research by dedicated scientists and clinicians from a wide range of disciplines advances our ...

When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.